AtriCure Historical Cash Flow
| ATRC Stock | USD 36.01 0.27 0.76% |
Analysis of AtriCure cash flow over time is an excellent tool to project AtriCure future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as End Period Cash Flow of 88.5 M or Change In Cash of 27.5 M as it is a great indicator of AtriCure ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining AtriCure latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether AtriCure is a good buy for the upcoming year.
AtriCure |
About AtriCure Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in AtriCure balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which AtriCure's non-liquid assets can be easily converted into cash.
AtriCure Cash Flow Chart
Add Fundamental
Capital Expenditures
Capital Expenditures are funds used by AtriCure to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of AtriCure operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.Begin Period Cash Flow
The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.Net Income
Net income is one of the most important fundamental items in finance. It plays a large role in AtriCure financial statement analysis. It represents the amount of money remaining after all of AtriCure operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.Stock Based Compensation
Compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders.Net Borrowings
The difference between the amount of new debt a company has taken on and the amount of debt it has paid off during a given period.Most accounts from AtriCure's cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into AtriCure current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in AtriCure. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. For information on how to trade AtriCure Stock refer to our How to Trade AtriCure Stock guide.At present, AtriCure's End Period Cash Flow is projected to increase significantly based on the last few years of reporting. The current year's Change In Cash is expected to grow to about 27.5 M, whereas Total Cash From Financing Activities is projected to grow to (30.4 K).
AtriCure cash flow statement Correlations
Click cells to compare fundamentals
AtriCure Account Relationship Matchups
High Positive Relationship
High Negative Relationship
AtriCure cash flow statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Capital Expenditures | 12.2M | 5.3M | 9.8M | 16.9M | 42.0M | 44.1M | |
| Total Cash From Financing Activities | 14.4M | 189.4M | (7.6M) | (7.1M) | (32K) | (30.4K) | |
| End Period Cash Flow | 28.5M | 41.9M | 43.7M | 58.1M | 84.3M | 88.5M | |
| Change To Liabilities | 5.9M | (6.5M) | 13.0M | (289K) | (332.4K) | (315.7K) | |
| Change To Inventory | (5.2M) | (5.3M) | (4.3M) | (7.3M) | (21.8M) | (20.7M) | |
| Change In Cash | (3.7M) | 13.5M | 1.7M | 14.4M | 26.2M | 27.5M | |
| Free Cash Flow | (28.0M) | (25.1M) | (23.5M) | (39.0M) | (37.5M) | (35.6M) | |
| Change In Working Capital | (4.6M) | (6.6M) | (4.8M) | (18.9M) | (18.2M) | (17.3M) | |
| Begin Period Cash Flow | 32.2M | 28.5M | 41.9M | 43.7M | 58.1M | 61.0M | |
| Other Cashflows From Financing Activities | 24.0M | 28.3M | 11.2M | 6.0M | 7.5M | 7.1M | |
| Depreciation | 9.4M | 9.5M | 10.4M | 11.7M | 14.8M | 15.6M | |
| Other Non Cash Items | (3.8M) | 1.2M | (182.4M) | 2.7M | 2.6M | 2.8M | |
| Total Cash From Operating Activities | (15.8M) | (19.9M) | (13.8M) | (22.1M) | 4.5M | 4.7M | |
| Net Income | (35.2M) | (48.2M) | 50.2M | (46.5M) | (30.4M) | (28.9M) | |
| Change To Account Receivables | (3.2M) | 5.1M | (10.1M) | (9.0M) | (9.9M) | (9.4M) | |
| Total Cashflows From Investing Activities | (2.1M) | (156.2M) | 23.5M | 44.0M | 39.6M | 41.6M | |
| Stock Based Compensation | 18.0M | 22.6M | 28.1M | 28.8M | 35.7M | 37.5M | |
| Other Cashflows From Investing Activities | 10.1M | 6K | (17.2M) | 800K | 720K | 756K | |
| Sale Purchase Of Stock | (9.0M) | (13.0M) | (18.0M) | (12.2M) | (6.6M) | (6.9M) | |
| Investments | 27.2M | (151.7M) | 33.3M | 60.9M | 21.8M | 22.9M | |
| Change Receivables | (3.2M) | 5.1M | (10.1M) | (9.0M) | (8.1M) | (7.7M) | |
| Net Borrowings | 19.7M | (35K) | 3.8M | (899K) | (1.0M) | (982.2K) | |
| Exchange Rate Changes | (179K) | (163K) | 136K | (372K) | (334.8K) | (318.1K) | |
| Dividends Paid | 3.9M | 14.2M | 12.4M | 6.0M | 60K | 57K | |
| Cash And Cash Equivalents Changes | (3.7M) | 13.5M | 1.7M | 14.8M | 17.0M | 17.9M | |
| Cash Flows Other Operating | (828K) | 7K | (3.5M) | (2.3M) | (2.1M) | (2.0M) | |
| Change To Netincome | 13.8M | 23.6M | (72.8M) | 29.5M | 26.6M | 27.9M | |
| Change To Operating Activities | 947K | (4.9M) | 4.8M | (5.3M) | (4.7M) | (4.5M) |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether AtriCure offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of AtriCure's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Atricure Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Atricure Stock:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in AtriCure. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. For information on how to trade AtriCure Stock refer to our How to Trade AtriCure Stock guide.You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of AtriCure. If investors know AtriCure will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about AtriCure listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.83) | Revenue Per Share 9.564 | Quarterly Revenue Growth 0.179 | Return On Assets (0.04) | Return On Equity (0.08) |
The market value of AtriCure is measured differently than its book value, which is the value of AtriCure that is recorded on the company's balance sheet. Investors also form their own opinion of AtriCure's value that differs from its market value or its book value, called intrinsic value, which is AtriCure's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because AtriCure's market value can be influenced by many factors that don't directly affect AtriCure's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between AtriCure's value and its price as these two are different measures arrived at by different means. Investors typically determine if AtriCure is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, AtriCure's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.